Applied Molecular Transport Inc.
NASDAQ:AMTI

Watchlist Manager
Applied Molecular Transport Inc. Logo
Applied Molecular Transport Inc.
NASDAQ:AMTI
Watchlist
Price: 0.263 USD Market Closed
Updated: May 31, 2024

Applied Molecular Transport Inc.
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Applied Molecular Transport Inc.
Capital Expenditures Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Applied Molecular Transport Inc.
NASDAQ:AMTI
Capital Expenditures
-$4.2m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Capital Expenditures
-$795m
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Capital Expenditures
-$581m
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
-6%
Amgen Inc
NASDAQ:AMGN
Capital Expenditures
-$998m
CAGR 3-Years
-16%
CAGR 5-Years
-7%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Capital Expenditures
-$464.7m
CAGR 3-Years
-14%
CAGR 5-Years
-41%
CAGR 10-Years
-25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Capital Expenditures
-$809.1m
CAGR 3-Years
-13%
CAGR 5-Years
-16%
CAGR 10-Years
-15%

See Also

What is Applied Molecular Transport Inc.'s Capital Expenditures?
Capital Expenditures
-4.2m USD

Based on the financial report for Dec 31, 2022, Applied Molecular Transport Inc.'s Capital Expenditures amounts to -4.2m USD.

What is Applied Molecular Transport Inc.'s Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-25%

Over the last year, the Capital Expenditures growth was -123%. The average annual Capital Expenditures growth rates for Applied Molecular Transport Inc. have been -25% over the past three years .